• Toxocariasis
  • Electrophoresis, Protein, CSF
  • Tuberculosis Cell Mediated Immunity Antigen Response (T-SPOTĀ®. TB) Test
  • Tissue Transglutaminase (tTG) Antibody, IgA
  • Benzene Quantitative, Whole Blood
  • Clonorchis sinensis Antibody, IgG4
  • Alkaline Phosphatase (ALP), Serum
  • Testosterone, Bioavailable
  • CHIC2, 4q12 Deletion (FIP1L1 and PDGFRA Fusion), FISH, Blood
  • Erythrocyte Sedimentation Rate (ESR)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.